Citation:Atagi S, Kawahara M, Yokoyama A, Okamoto H, Yamamoto N, Ohe Y, et al 2012

From Cancer Guidelines Wiki

Citation


Atagi S, Kawahara M, Yokoyama A, Okamoto H, Yamamoto N, Ohe Y, et al. Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301). Lancet Oncol 2012 Jul;13(7):671-8 Available from: http://www.ncbi.nlm.nih.gov/pubmed/22622008.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Japan Clinical Oncology Group Lung Cancer Study Group, Atagi S, Kawahara M, Yokoyama A, Okamoto H, Yamamoto N, et al 2012What is the recommended treatment approach for the definitive management of patients with good performance status and inoperable stage III disease?Dr Margot Lehman MBBS FRANZCR GDPcompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What is the recommended treatment approach for the definitive management of patients with good performance status and inoperable stage III disease?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the recommended treatment approach for the definitive management of patients with good performance status and inoperable stage III disease?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. What is the recommended treatment approach for the definitive management of patients with good performance status and inoperable stage III disease?
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Atagi_S,_Kawahara_M,_Yokoyama_A,_Okamoto_H,_Yamamoto_N,_Ohe_Y,_et_al_2012&oldid=95140"